Keywords: Sigma, Aspen, Generics unit, M&A
Sigma Pharma tells suitor Aspen it wants a higher takeover offer
Article | 13 July 2010
Following last week’s decision by South Africa’s largest drugmaker Aspen Pharmacare to reduce its previously-announced non-binding takeover offer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
